Dra. Anna Veiga (IMAGE)

IDIBELL-Bellvitge Biomedical Research Institute

Dra. Anna Veiga

Caption

The study aim is to determine the involvement of several genes in early stages of human embryonic development. To achieve this goal, Dr. Veiga's team will modify these genes by the genome editing technique CRISPR/Cas9, and they will study the development of the edited embryos. This is a unique and pioneering project in this field in Spain, which will provide very relevant information to understand the early development of the human embryo, and potentially improve assisted reproduction techniques.

Credit

: Bellvitge Biomedicine Research Institute (IDIBELL)

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.